Pacific Biosciences Of California (PACB) Invested Capital (2016 - 2025)
Historic Invested Capital for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $36.1 million.
- Pacific Biosciences Of California's Invested Capital fell 9203.53% to $36.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.1 million, marking a year-over-year decrease of 9203.53%. This contributed to the annual value of $506.6 million for FY2024, which is 2776.4% down from last year.
- Latest data reveals that Pacific Biosciences Of California reported Invested Capital of $36.1 million as of Q3 2025, which was down 9203.53% from $61.5 million recorded in Q2 2025.
- In the past 5 years, Pacific Biosciences Of California's Invested Capital registered a high of $876.5 million during Q1 2023, and its lowest value of $36.1 million during Q3 2025.
- In the last 5 years, Pacific Biosciences Of California's Invested Capital had a median value of $649.0 million in 2024 and averaged $553.0 million.
- Its Invested Capital has fluctuated over the past 5 years, first surged by 54929.19% in 2021, then crashed by 9203.53% in 2025.
- Pacific Biosciences Of California's Invested Capital (Quarter) stood at $792.6 million in 2021, then dropped by 7.27% to $735.0 million in 2022, then fell by 4.58% to $701.3 million in 2023, then decreased by 27.76% to $506.6 million in 2024, then crashed by 92.88% to $36.1 million in 2025.
- Its last three reported values are $36.1 million in Q3 2025, $61.5 million for Q2 2025, and $91.6 million during Q1 2025.